Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL
Holding AUTL?
Track your performance easily

Autolus Therapeutics (AUTL) Financial Statements

560 Followers

Autolus Therapeutics Financial Overview

Autolus Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.163; its P/E ratio is -3.01; Autolus Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 61.00K$ 10.09M-$ 2.37M$ 0.00
Gross Profit$ 61.00K$ 10.09M---
EBIT$ -48.05M$ -33.43M-$ -47.07M$ -47.72M
EBITDA$ -46.15M$ -31.62M-$ -45.28M$ -45.80M
Net Income Common Stockholders$ -48.10M$ -52.69M-$ -42.77M$ -42.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 705.94M$ 758.53M$ 382.76M$ 163.05M$ 216.44M
Total Assets$ 853.62M$ 901.44M$ 490.27M$ 263.83M$ 313.98M
Total Debt$ 50.02M$ 51.34M$ 24.26M$ 15.13M$ 17.20M
Net Debt$ -655.92M$ -707.19M$ -358.50M$ -147.93M$ -199.23M
Total Liabilities$ 325.78M$ 319.41M$ 191.60M$ 102.68M$ 99.45M
Stockholders Equity$ 527.73M$ 582.03M$ 298.67M$ 161.15M$ 214.52M
Cash Flow-
Free Cash Flow$ -51.92M$ -41.05M-$ -38.70M$ -33.45M
Operating Cash Flow$ -51.08M$ -40.51M-$ -31.90M$ -30.81M
Investing Cash Flow$ -841.00K$ -533.00K-$ -6.80M$ -2.64M
Financing Cash Flow$ -2.08M$ 561.44M-$ 102.00K$ 0.00
Currency in USD

Autolus Therapeutics Earnings and Revenue History

Autolus Therapeutics Debt to Assets

Autolus Therapeutics Cash Flow

Autolus Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis